VICTORY FINANCIAL GROUP, LLC

Position in ABBV — AbbVie Inc.

CIK 2011333 AUSTIN, TX

Position in ABBV

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$2,230,285

+$363,786 QoQ

Shares Held

8,863

+3.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.94%

of 13F equity value

Holder Rank

#1,877

of 4,153 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY FINANCIAL GROUP, LLC holds $10,640,896 across 7 Drug Manufacturers - General names. ABBV ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,281	$3,935,330
2	ABBV	AbbVie Inc. This page	8,863	$2,230,285
3	JNJ	Johnson & Johnson	7,361	$1,869,473
4	AMGN	Amgen Inc	2,418	$875,606
5	MRK	Merck & Co., Inc.	5,874	$754,809
6	GSK	GSK plc	11,703	$613,471
7	PFE	Pfizer Inc	15,030	$361,922

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,230,285	8,863	+3.3%	Shares	Sole	2026-07-29
2026-03-31	$1,866,499	8,582	+11.4%	Shares	Sole	2026-04-27
2025-12-31	$1,760,743	7,706	+38.5%	Shares	Sole	2026-01-15
2025-09-30	$1,288,520	5,565	+3.7%	Shares	Sole	2025-11-14
2025-06-30	$996,222	5,367	+55.5%	Shares	Sole	2025-08-13
2025-03-31	$723,263	3,452	+112.6%	Shares	Sole	2025-05-12
2024-12-31	$288,584	1,624	—	Shares	Sole	2025-02-11
No filing history on record for this holder in this stock.